From: Local use of dexamethasone in the treatment of ocular myasthenia gravis
Author | Drug and treatment objects | Follow-up Time | Number of cases | Complete remission rate at the end of follow-up |
---|---|---|---|---|
Mark J. Kupersmith [16] | Prednisone for OMG | 2 years | 55 | 12 patients(21.8%) |
Kyung-Ah Park [17] | prednisone and/or azathiorpine for Initial MG with diplopia | 45.4 ± 39.7 months | 28 | 6 patients (21.4%) |
Kavin Vanikieti [6] | prednisone and/or pyridostigmine for juvenile OMG | 95 months | 62 | Blepharoptosis:13 of 60 (21.67%); ophthalmoplegia:3of 38 (7.9%) . |
Our study | Dexamethasone peribulbar or extraocular muscle injection for OMG | 16.0 ± 6.33 months | 14 | 11 patients(78.5%) |